Electric fields take on pancreatic cancer: new hope for patients

NCT ID NCT07319910

TEMPORARILY_NOT_AVAILABLE Disease control Sponsor: NovoCure GmbH Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 22 times

Summary

This program gives adults with locally advanced pancreatic cancer access to a treatment that uses electric fields (TTFields) together with standard chemotherapy. The goal is to control the disease while the device is being reviewed by the FDA. Participants must be able to manage the device themselves or with help from a caregiver.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

Explore the condition pages connected to this study.